According to the hypothesis, the present study, for the first time, demonstrated that the intraperitoneal injection of low-dose IL-2 markedly treated depression- and anxiety-like behaviors by restoring the imbalance between Treg and Th17 in the hippocampus of CUMS mice. This evidence concerns the gene IL2 and major depressive disorder.